XML 39 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 8 - Accrued Expenses and Other Current Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] | Note 8. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following:
|  | December 31, 2024 |  |  | December 31, 2023 |
Employee compensation costs |  | $ | 803,193 |  |  | $ | 1,026,054 |
Clinical development costs |  |  | 1,158,783 |  |  |  | 389,045 |
Professional fees |  |  | 249,527 |  |  |  | 309,062 |
State franchise and excise tax |  |  | 40,456 |  |  |  | 120,456 |
Other |  |  | 115,883 |  |  |  | 88,659 |
Total |  | $ | 2,367,842 |  |  | $ | 1,933,276 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration